Working to end evidence distortion in medicine
#clinicaltrials#transparency. Tweets by Till Bruckner.
ACCOUNT CURRENTLY NOT ACTIVELY MANAGED - EMAIL ME.
FDA to powerful companies and institutions:
"You can break the law as much as you like, we will never take you to court."
Seriously @DrCaliff_FDA ?
https://t.co/xh99FpRcuu @drjohnm@Marguerite_OR
And... we have a breakdown of the compromise amendments here: including orphan drugs, launch mechanism, transferable exclusivity voucher and HERA in the ECDC (!?)
https://t.co/8Ov9JMLXPL
@david_colquhoun You should blog for @LSEImpactBlog about how academia has changed over these decades and what the impact on science and society has been
I am no longer a professor of medicine at @Harvard. Here is the story of my Harvard experience until I was fired for clinging to the truth.
https://t.co/zSOQlNJTY2
Exciting News! The iRISE Consortium is launching a pioneering intervention study to enhance research reproducibility through computational methods, led by Gustav Nilsonne. Stay tuned for updates as we team up with top academic journals to execute our protocol.
Nominations are open for the 2024 #MaddoxPrize for standing up for science.
Nominate someone who has who spoken out for sound science and evidence, and made change happen in public discourse, opinion or policy: https://t.co/04pqLoPeyz @SpringerNature https://t.co/iyQqdNr4KZ
“Essentially, the FDA said, ‘You can’t trust any of this.’ But the company used the results”
-> Footnote: far too few academics file #FOIA requests
https://t.co/IcMY67J2VF @cpiller@Strech_Da
Today, the UKRN’s OR4 project releases a new report that describes the UK landscape of responsible researcher assessment, with a particular focus on open research. Led by Robert Darby from the University of Reading. https://t.co/ZrLgkRgify
@johnarnold Kimberley-Strassel's book is great on that episode.
In the UK it takes >1 year to set up a full-blown charity and they are overseen by a dedicated (but overstretched) regulator. But similar debates about red lines for political engagement.